Cargando…
Therapeutic Targeting of Protein Disulfide Isomerase PDIA1 in Multiple Myeloma
SIMPLE SUMMARY: Multiple myeloma (MM) is a cancer of antibody-producing plasma cells that remains incurable. These cells heavily depend on protein disulfide isomerase, PDIA1, for folding and structural integrity of antibodies and other secretory proteins to avoid unresolvable stress caused if they r...
Autores principales: | Hasipek, Metis, Grabowski, Dale, Guan, Yihong, Alugubelli, Raghunandan Reddy, Tiwari, Anand D., Gu, Xiaorong, DeAvila, Gabriel A., Silva, Ariosto S., Meads, Mark B., Parker, Yvonne, Lindner, Daniel J., Saunthararajah, Yogen, Shain, Kenneth H., Maciejewski, Jaroslaw P., Reu, Frederic J., Phillips, James G., Jha, Babal K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198550/ https://www.ncbi.nlm.nih.gov/pubmed/34071205 http://dx.doi.org/10.3390/cancers13112649 |
Ejemplares similares
-
Eltrombopag inhibits TET dioxygenase to contribute to hematopoietic stem cell expansion in aplastic anemia
por: Guan, Yihong, et al.
Publicado: (2022) -
Protective Role for the Disulfide Isomerase PDIA3 in Methamphetamine Neurotoxicity
por: Pendyala, Gurudutt, et al.
Publicado: (2012) -
Influence of Ellagitannins Extracted by Pomegranate Fruit on Disulfide Isomerase PDIA3 Activity
por: Altieri, Fabio, et al.
Publicado: (2019) -
Decitabine- and 5-azacytidine resistance emerges from adaptive responses of the pyrimidine metabolism network
por: Gu, Xiaorong, et al.
Publicado: (2020) -
Protein Disulfide Isomerase A3 (PDIA3): A Pharmacological Target in Glioblastoma?
por: Paglia, Giuliano, et al.
Publicado: (2023)